Singular Genomics shares are trading lower after the company announced a 1-for-30 reverse stock split.
Portfolio Pulse from Benzinga Newsdesk
Singular Genomics shares are trading lower after the company announced a 1-for-30 reverse stock split.
June 24, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Singular Genomics shares are trading lower after the company announced a 1-for-30 reverse stock split.
Reverse stock splits are often perceived negatively by investors as they can indicate financial instability or an attempt to meet listing requirements. This has led to a decline in Singular Genomics' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100